Clinical Trial Update: COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial of a COX-2 inhibitor in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• COX-2 inhibitor (COX-2 inhibitor)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED